Comparative differential cytotoxicity of clinically used SERMs in human cancer lines of different origin and its predictive molecular docking studies of key target genes involved in cancer progression and treatment responses
SERMS like Tamoxifene, 5-hydroxy tamoxifene, raloxifene and endoxifene has been used for the treatment of hormonal imbalances and dependent cancers owing to their action via Estrogen receptors as in the treatment of estrogen sensitive breast cancers. Due to the adverse side effects, modifications an...
Main Authors: | Lakshmi S, Shanitha A, Shiny Dv, Rahul Bs, Saikant R, Shehna Sharaf, Abi Sa, Rajmohan G |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-01-01
|
Series: | Current Research in Pharmacology and Drug Discovery |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2590257121000675 |
Similar Items
-
The immune activity of selective estrogen receptor modulators is gene and macrophage subtype-specific yet converges on Il1b downregulation
by: Chiara Sfogliarini, et al.
Published: (2023-09-01) -
Chemoprevention of Breast Cancer: The Paradox of Evidence versus Advocacy Inaction
by: Rakhshanda Layeequr Rahman, et al.
Published: (2012-10-01) -
Manipulating Estrogenic/Anti-Estrogenic Activity of Triphenylethylenes towards Development of Novel Anti-Neoplastic SERMs
by: Heba E. Elnakib, et al.
Published: (2021-11-01) -
<i>FLTX2</i>: A Novel Tamoxifen Derivative Endowed with Antiestrogenic, Fluorescent, and Photosensitizer Properties
by: Mario Díaz, et al.
Published: (2021-05-01) -
A state-of-the-art review of tamoxifen as a potential therapeutic for duchenne muscular dystrophy
by: Valeria Botti, et al.
Published: (2022-11-01)